Does vaccination with Ad35, Ad26, and Ad48 elicit higher levels of innate cytokine responses than Ad5 in rhesus monkeys?
Adenovirus vectors utilizing CD46 as their primary cellular receptor (Ad35, Ad26, Ad48) induce significantly greater innate cytokine responses than Ad5, which uses the CAR receptor.
Adenovirus (Ad) vaccine vectors have proven highly immunogenic in multiple experimental models, but the innate immune responses induced by these vectors remain poorly characterized. Here we report innate cytokine responses to 5 different Ad vectors in 26 rhesus monkeys. Vaccination with adenovirus serotype 35 (Ad35), Ad26, and Ad48 induced substantially higher levels of antiviral (gamma interferon IFN-γ, 10-kDa gamma interferon-induced protein IP-10) and proinflammatory (interleukin 1 receptor antagonist IL-1RA, IL-6) cytokines than vaccination with Ad5 on day 1 following immunization. In vitro studies with capsid chimeric vectors and receptor-blocking monoclonal antibodies suggested that fiber-receptor interactions, as well as other capsid components, were critical for triggering these innate responses. Moreover, multiple cell populations, including dendritic cells, monocytes/macrophages, and T lymphocytes, contributed to these innate cytokine profiles. These data demonstrate that Ad35, Ad26, and Ad48, which utilize CD46 as their primary cellular receptor, induce significantly greater innate cytokine responses than Ad5, which uses the coxsackievirus and adenovirus receptor (CAR). These differences in innate triggering result in markedly different immunologic milieus for the subsequent generation of adaptive immune responses by these vaccine vectors.
Teigler et al. (2012) studied this question.